Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 12690

1.

Right atrial epithelioid angiosarcoma with multiple pulmonary metastasis confirmed by multimodality imaging-guided pulmonary biopsy: A case report and literature review.

Liu C, Zhao Y, Yin Z, Hu T, Ren J, Wei J, Xie L, Xiong J, Wu H, Dai X, Fei S.

Medicine (Baltimore). 2018 Jul;97(30):e11588. doi: 10.1097/MD.0000000000011588. Review.

2.

Rapid Fire: Superior Vena Cava Syndrome.

Zimmerman S, Davis M.

Emerg Med Clin North Am. 2018 Aug;36(3):577-584. doi: 10.1016/j.emc.2018.04.011. Epub 2018 Jun 12. Review.

PMID:
30037444
3.

Prognostic role of snail in lung cancer: Protocol for a systematic review.

Li M, Zhang X, Hu K, Shi M, Dong G, Li D, Zhang P.

Medicine (Baltimore). 2018 Jul;97(28):e11539. doi: 10.1097/MD.0000000000011539. Review.

4.

A meta-analysis of the relationship between environmental tobacco smoke and lung cancer risk of nonsmoker in China.

Sheng L, Tu JW, Tian JH, Chen HJ, Pan CL, Zhou RZ.

Medicine (Baltimore). 2018 Jul;97(28):e11389. doi: 10.1097/MD.0000000000011389. Review.

5.
6.

Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds.

Maiuthed A, Chantarawong W, Chanvorachote P.

Anticancer Res. 2018 Jul;38(7):3797-3809. doi: 10.21873/anticanres.12663. Review.

PMID:
29970499
7.

Heterogeneity of PD-L1 Expression and Relationship with Biology of NSCLC.

Bassanelli M, Sioletic S, Martini M, Giacinti S, Viterbo A, Staddon A, Liberati F, Ceribelli A.

Anticancer Res. 2018 Jul;38(7):3789-3796. doi: 10.21873/anticanres.12662. Review.

PMID:
29970498
8.

Rapid biomarker testing for improved clinical decision-making in nonsmall cell lung cancer.

Kaplan EH.

MLO Med Lab Obs. 2017 Jun;49(6):12-4, 16-8. Review. No abstract available.

PMID:
29952196
9.

Role of Dual-Energy Computed Tomography in Thoracic Oncology.

Odisio EG, Truong MT, Duran C, de Groot PM, Godoy MC.

Radiol Clin North Am. 2018 Jul;56(4):535-548. doi: 10.1016/j.rcl.2018.03.011. Review.

PMID:
29936946
10.

Surgical treatment of pulmonary metastasis in colorectal cancer patients: Current practice and results.

Zellweger M, Abdelnour-Berchtold E, Krueger T, Ris HB, Perentes JY, Gonzalez M.

Crit Rev Oncol Hematol. 2018 Jul;127:105-116. doi: 10.1016/j.critrevonc.2018.05.001. Epub 2018 Jun 4. Review.

PMID:
29891107
11.

Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment.

El Rassy E, Botticella A, Kattan J, Le Péchoux C, Besse B, Hendriks L.

Cancer Treat Rev. 2018 Jul;68:69-79. doi: 10.1016/j.ctrv.2018.05.015. Epub 2018 May 31. Review.

12.

Primary ovarian small cell carcinoma of pulmonary type with coexisting endometrial carcinoma in a breast cancer patient receiving tamoxifen: A case report and literature review.

Yin L, Li J, Wei Y, Ma D, Sun Y, Sun Y.

Medicine (Baltimore). 2018 Jun;97(23):e10900. doi: 10.1097/MD.0000000000010900. Review.

13.

Endoluminal brachytherapy: Bronchus and oesophagus.

Hennequin C, Guillerm S, Wong S, Quéro L.

Cancer Radiother. 2018 Jun;22(4):367-371. doi: 10.1016/j.canrad.2017.11.013. Epub 2018 May 30. Review.

PMID:
29858135
14.

Toward innovative combinational immunotherapy: A systems biology perspective.

Li XT, Yang JJ, Wu YL, Hou J.

Cancer Treat Rev. 2018 Jul;68:1-8. doi: 10.1016/j.ctrv.2018.05.003. Epub 2018 May 8. Review.

PMID:
29775845
15.

Tumoral cavitation in colorectal cancer patients with unresectable lung metastasis treated with bevacizumab and chemotherapy.

Peng Y, Chen Y, Zhang X, Yang Y, Cao D, Bi F, Li Z, Gou H.

J Cancer Res Clin Oncol. 2018 Jul;144(7):1339-1346. doi: 10.1007/s00432-018-2656-y. Epub 2018 May 17. Review.

16.

Lung cancer screening CT-based coronary artery calcification in predicting cardiovascular events: A systematic review and meta-analysis.

Fan L, Fan K.

Medicine (Baltimore). 2018 May;97(20):e10461. doi: 10.1097/MD.0000000000010461. Review.

17.

Anticancer drug treatment for advanced lung cancer with interstitial lung disease.

Otsubo K, Okamoto I, Hamada N, Nakanishi Y.

Respir Investig. 2018 Jul;56(4):307-311. doi: 10.1016/j.resinv.2018.03.002. Epub 2018 Apr 13. Review.

PMID:
29764748
18.

Development of targeted therapy and immunotherapy for treatment of small cell lung cancer.

Saito M, Shiraishi K, Goto A, Suzuki H, Kohno T, Kono K.

Jpn J Clin Oncol. 2018 Jul 1;48(7):603-608. doi: 10.1093/jjco/hyy068. Review.

PMID:
29762727
19.

Consolidation systemic treatment after radiochemotherapy for unresectable stage III non-small cell lung cancer.

Skrzypski M, Jassem J.

Cancer Treat Rev. 2018 May;66:114-121. doi: 10.1016/j.ctrv.2018.04.001. Epub 2018 Apr 5. Review.

PMID:
29738940
20.

BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall.

Leonetti A, Facchinetti F, Rossi G, Minari R, Conti A, Friboulet L, Tiseo M, Planchard D.

Cancer Treat Rev. 2018 May;66:82-94. doi: 10.1016/j.ctrv.2018.04.006. Epub 2018 Apr 24. Review.

PMID:
29729495

Supplemental Content

Loading ...
Support Center